Epstein-Barr virus: An important vaccine target for cancer prevention

Jeffrey I. Cohen; Anthony S. Fauci; Harold Varmus; Gary J. Nabel

doi:10.1126/scitranslmed.3002878

Epstein-Barr virus: An important vaccine target for cancer prevention

Jeffrey I. Cohen, Anthony S. Fauci, Harold Varmus, Gary J. Nabel

Research output: Contribution to journal › Article › peer-review

191 Scopus citations

Abstract

Participants at the February 2011 meeting at the U.S. National Institutes of Health on Epstein-Barr virus (EBV) vaccine research recommend that future clinical trials have two goals: prevention of infectious mononucleosis and EBV-associated cancers, facilitated by identification of disease-predictive surrogate markers.

Original language	English (US)
Article number	107fs7
Journal	Science Translational Medicine
Volume	3
Issue number	107
DOIs	https://doi.org/10.1126/scitranslmed.3002878
State	Published - Nov 2 2011
Externally published	Yes

ASJC Scopus subject areas

General Medicine

Access to Document

10.1126/scitranslmed.3002878

Cite this

@article{c90e7b6f6e0f475aa76dbab39798b604,

title = "Epstein-Barr virus: An important vaccine target for cancer prevention",

abstract = "Participants at the February 2011 meeting at the U.S. National Institutes of Health on Epstein-Barr virus (EBV) vaccine research recommend that future clinical trials have two goals: prevention of infectious mononucleosis and EBV-associated cancers, facilitated by identification of disease-predictive surrogate markers.",

author = "Cohen, {Jeffrey I.} and Fauci, {Anthony S.} and Harold Varmus and Nabel, {Gary J.}",

year = "2011",

month = nov,

day = "2",

doi = "10.1126/scitranslmed.3002878",

language = "English (US)",

volume = "3",

journal = "Science Translational Medicine",

issn = "1946-6234",

publisher = "American Association for the Advancement of Science",

number = "107",

}

TY - JOUR

T1 - Epstein-Barr virus

T2 - An important vaccine target for cancer prevention

AU - Cohen, Jeffrey I.

AU - Fauci, Anthony S.

AU - Varmus, Harold

AU - Nabel, Gary J.

PY - 2011/11/2

Y1 - 2011/11/2

N2 - Participants at the February 2011 meeting at the U.S. National Institutes of Health on Epstein-Barr virus (EBV) vaccine research recommend that future clinical trials have two goals: prevention of infectious mononucleosis and EBV-associated cancers, facilitated by identification of disease-predictive surrogate markers.

AB - Participants at the February 2011 meeting at the U.S. National Institutes of Health on Epstein-Barr virus (EBV) vaccine research recommend that future clinical trials have two goals: prevention of infectious mononucleosis and EBV-associated cancers, facilitated by identification of disease-predictive surrogate markers.

UR - http://www.scopus.com/inward/record.url?scp=80455164859&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80455164859&partnerID=8YFLogxK

U2 - 10.1126/scitranslmed.3002878

DO - 10.1126/scitranslmed.3002878

M3 - Article

C2 - 22049067

AN - SCOPUS:80455164859

SN - 1946-6234

VL - 3

JO - Science Translational Medicine

JF - Science Translational Medicine

IS - 107

M1 - 107fs7

ER -

Epstein-Barr virus: An important vaccine target for cancer prevention

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this